Stock News & Analysis

While Microsoft's heavy AI spending appears worrisome today, it could become the foundation for stronger cloud growth and AI monetization in future years.

These stocks are all trading at a discount today.

Spyre Therapeutics focuses on antibody therapies for inflammatory bowel disease, advancing a pipeline aimed at gastrointestinal health.

A hotter-than-expected PPI could be bad news for investors.

These two artificial intelligence (AI) giants offer alternatives to Nvidia's powerful GPUs.

TSMC's competitive moat sets it up for longevity.

Amazon's cloud computing segment is growing at its fastest pace in years, but a staggering new $200 billion spending plan has investors questioning the stock's future.

Don't let a missed RMD cost you unnecessarily.

Verizon has a lofty 5.5% yield, but don't expect material dividend growth in the near term.

Powell and his fellow members of the Federal Open Market Committee (FOMC) can't sweep this Wall Street threat under the rug any longer.

A Fed decision and bearish forecasts led to a modest sell-off.

Both its own executives and analysts are extremely optimistic about its future.

Robotics could be the next frontier in the AI revolution.

The semiconductor specialist's blistering growth continued to accelerate.

This company's massive infrastructure spending might look intimidating, but the impressive growth coming from its cloud business makes these expenditures worthwhile.

Robust top-line growth in its fourth quarter wowed investors.

Expense ratios, diversification, and fund size set these two real estate ETFs apart.

Is Microsoft poised for continued success, or is its valuation too high? Join us as we explore the bull and bear cases for this tech giant.

An analyst bumped his price target higher on the popular cloud computing specialist.

On March 18, 2026, investors weigh a turnaround story against potential legal issues and sector declines.